Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects

Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors